GRCL

Gracell Biotechnologies Inc. (GRCL)

US
$ 10.250.05%

Price Chart

Key Statistics

Market Cap
$ 989.87M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
6.42M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
-0.34

Technicals

50-Day MA
9.5389
200-Day MA
5.2413
52 Week High
N/A
52 Week Low
N/A

About GRCL

Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China.

Employees
314
Headquarters
Suzhou, China
CEO
Dr. Wei Cao BM, Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg